Biomerica Launches IBS Product in Canada

Biomerica has officially launched its inFoods IBS diagnostic-guided therapy in Canada, marking its first commercial entry into the Canadian market for this specific product. This launch was facilitated through strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs. The introduction of inFoods IBS aims to provide a precision diagnostic solution for individuals suffering from Irritable Bowel Syndrome (IBS), a condition notably prevalent in Canada. This expansion represents a significant step for Biomerica in broadening its global reach and addressing unmet medical needs.